Berry Genomics Co.,Ltd (SHE:000710)

China flag China · Delayed Price · Currency is CNY
11.88
+0.11 (0.93%)
Mar 10, 2026, 1:15 PM CST
-31.37%
Market Cap 4.16B
Revenue (ttm) 941.16M
Net Income (ttm) -255.38M
Shares Out 353.52M
EPS (ttm) -0.72
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,415,300
Average Volume 9,093,955
Open 11.70
Previous Close 11.77
Day's Range 11.70 - 12.02
52-Week Range 10.18 - 19.55
Beta 0.58
RSI 43.60
Earnings Date Apr 29, 2026

About Berry Genomics Co.,Ltd

Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcriptional regulation, single cell/spatial sequencing, animal and plant genome resequencing, genome denovo sequencing, and microbial sequencing, as well a... [Read more]

Sector Healthcare
Founded 2010
Employees 1,402
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000710
Full Company Profile

Financial Performance

In 2024, Berry Genomics Co.,Ltd's revenue was 1.08 billion, a decrease of -6.36% compared to the previous year's 1.15 billion. Losses were -192.43 million, -54.96% less than in 2023.

Financial Statements

News

There is no news available yet.